InflaRx (IFRX) Interest Income - Net (2017 - 2026)
InflaRx's (IFRX) quarterly Interest Income - Net came in at -$17400.6 in Q2 2026, down 4659.15% year-over-year from $381.66 in Q2 2025, and up 1.77% quarter-over-quarter from -$17713.4 in Q1 2026.
Powered by 
Analysis
InflaRx (IFRX) Interest Income - Net (2017 - 2026) Analysis & Trends
InflaRx has disclosed Interest Income - Net across 10 years of filings, most recently posting -$17400.6 for Q2 2026.
- In Q2 2026, Interest Income - Net fell 4659.15% year-over-year to -$17400.6; the TTM figure through Jun 2026 stood at -$66381.4 (down 138.87% YoY), while the FY2025 annual figure was -$38949.1, down 73.04% from the prior year.
- Interest Income - Net came in at -$17400.6 for Q2 2026 at InflaRx, up from -$17713.4 in the prior quarter.
- In the past five years, Interest Income - Net ranged from a high of -$365.62 in Q2 2025 to a low of -$27655.5 in Q1 2022.
- Average Interest Income - Net over 5 years is -$10665.0, with a median of -$7445.3 recorded in 2022.
- Year-over-year, Interest Income - Net surged 94.99% in 2023 and plunged 4659.15% in 2026.
- Over 5 years, Interest Income - Net stood at -$6088.8 in 2022, then tumbled by 257.87% to -$21789.9 in 2023, then jumped by 76.06% to -$5215.8 in 2024, then tumbled by 296.14% to -$20661.8 in 2025, then rose by 15.78% to -$17400.6 in 2026.
- Per Business Quant data, the three most recent Interest Income - Net figures were -$17400.6 in Q2 2026, -$17713.4 in Q1 2026, and -$20661.8 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Income - Net (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | InflaRx | 139.29 Mn | -44.96 Mn | 2.74 Mn | -17,400.56 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -17,400.56 |
| Mar 31, 2026 | -17,713.38 |
| Dec 31, 2025 | -20,661.77 |
| Sep 30, 2025 | -10,605.67 |
| Jun 30, 2025 | -365.62 |
| Mar 31, 2025 | -4,408.45 |
| Dec 31, 2024 | -5,215.81 |
| Sep 30, 2024 | -17,799.94 |
| Jun 30, 2024 | -2,214.08 |
| Mar 31, 2024 | -2,405.20 |
| Dec 31, 2023 | -21,789.94 |
| Sep 30, 2023 | -16,319.06 |
| Jun 30, 2023 | -395.28 |
| Mar 31, 2023 | -6,039.69 |
| Dec 31, 2022 | -6,088.84 |
| Sep 30, 2022 | -6,996.42 |
| Jun 30, 2022 | -7,894.09 |
| Mar 31, 2022 | -27,655.52 |
| Dec 31, 2021 | -9,793.54 |
| Sep 30, 2021 | -11,298.75 |